Hypertriglyceridemia: A contraindication to the use of bile acid binding resins-Reference-Cited by-同舟云学术

Hypertriglyceridemia: A contraindication to the use of bile acid binding resins

Published:1987-08 Issue:2 Volume:83 Page:243-248
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Crouse John R.

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. An approach to the management of hyperliproproteinemia;Hoeg;JAMA,1986

2. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism;Grundy;J Lab Clin Med,1971

3. Effects of colestipol, a new bile acid sequestering resin on cholesterol metabolism in man;Miller;J Lab Clin Med,1973

4. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism;Shepherd;N Engl J Med,1980

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review;Nutrients;2024-09-01

2. Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70−/− Mice with a Human-like Bile Acid Composition;Biomedicines;2023-09-08

3. Lactiplantibacillus plantarum PGB02 Improved Serum Cholesterol Profile by Tweaking Genes Involved in Cholesterol Homeostasis in Male Swiss Albino Mice;Applied Biochemistry and Biotechnology;2022-12-27

4. Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates;Environmental Science and Pollution Research;2022-03-22

5. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities;Seminars in Liver Disease;2021-07-21